E.g., 01/28/2020
E.g., 01/28/2020
Title Category Credit Event Datesort descending Price
Update Series (2018) Lesson 30: Definitions and Management of Oligometastatic Prostate Cancer
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$99.00 Now in its 37th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed in con­sultation with and edited by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology.Available in Two Formats
Update Series (2019) Lesson 7: Establishment of a Quality Assurance Framework for Introduction of Prostate Magnetic Resonance Imaging and Fusion...
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Now in its 38th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed in consultation with and edited by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology.
AUA Annual Meeting Highlights (2019): Prostate Cancer
    • 1.25 AMA PRA Category 1 Credit™
    • 1.25 Non-Physician Participation
$0.00 To better understand urologists’ educational needs for treating CRPC, the AUA conducted an in-depth educational needs assessment of its domestic membership representing >90% of U.S. Board Certified urologists in 2013 (Phase I). The AUA reassessed its member’s educational needs after releasing the updated CRPC Guideline and targeted CRPC educational activities in 2015 (Phase II) and again in 2017 (Phase III).
Update Series Volume 36 (2017)
    • 40.00 AMA PRA Category 1 Credit™
    • 40.00 Non-Physician Participation
$446.00 For the most timely topics and latest surgical techniques in urology, you won't want to miss the 2017 AUA Update Series—AUA's most popular self-study CME product.Concise, practical lessons on timely topicsState-of-the-art surgical techniquesAuthors are among the best in their specialtiesEarn up to 40 AMA PRA Category 1 Credits™
Update Series Volume 34 (2015)
    • 40.00 AMA PRA Category 1 Credit™
    • 40.00 Non-Physician Participation
$433.00 For the most timely topics and latest surgical techniques in urology, you won’t want to miss the 2015 AUA Update Series—the AUA’s most popular self-study CME product.All new topics for 2015!
Castration-Resistant Prostate Cancer (CRPC) Guideline Amendment Webcast (2018)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 To encourage consistent, high quality, evidence-based treatment of patients with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC), the AUA and Urology Care Foundation has produced a series of online activities and educational resources for healthcare professionals, patients and caregivers. One of those such activities is this complimentary AUA Castration-Resistant Prostate Cancer Guideline Amendment webcast.
Update Series (2018) Lesson 31: Stereotactic Body Radiation Therapy for the Management of Early Stage and Metastatic Prostate and Kidney Cancer
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$99.00 Now in its 37th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed in con­sultation with and edited by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology.Available in Two Formats
Highlights from AUA2019: Evolving Role of the Urologist in Metastatic and Castration Resistant Prostate Cancer (2019) $0.00 The AUA is launching an educational initiative to focus on resident and fellow training in the area of Advanced and Castration-Resistant Prostate Cancer. Based on the documented need for additional education in this area, the AUA has developed multiple educational interventions to improve the ability to care for patients with CRPC. These educational activities may also be of interest to advanced practice providers and urologists.
The Journal of Urology® Volumes 197/198 Home Study Course (2017)
    • 24.00 AMA PRA Category 1 Credit™
    • 24.00 Non-Physician Participation
$60.00 Most Comprehensive and Affordable Self-study CME Product!Make the most of your Journal of Urology® SubscriptionDeveloped by a team of educators, academicians, and clinicians, this valuable home study activity will enhance your knowledge of urology and improve performance as well as patient care at your convenience. For just $2.50 per credit, the Home Study program is designed to provide urologists and residents affordable access to the most recent developments and techniques in urology while reading The Journal®.
Oral Board Study Guide App (iOS and Android) $299.00 The AUA Oral Board Study Guide App features 68 interactive protocols in 34 topic areas. Developed by leading experts in urology, the app has been specifically designed for urologists preparing to take this examination and includes a strong emphasis on AUA Guidelines with direct access to the AUA Guidelines and the AUA Urology Core Curriculum for AUA members. Available for use on Apple and Android devices!
Update Series (2019) Lesson 26: Management of Castration Resistant Prostate Cancer
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Now in its 38th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed in consultation with and edited by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology.
Update Series (2019): Test Your Knowledge Lessons 1-5 $0.00 NEW – For our annual subscribers, we are excited to offer a new feature to the Update Series! If you like to answer questions to help you study and learn, we are now offering Test Your Knowledge activities with each release of the Update Series.  
Update Series (2016) Lesson 34: Tissue Based Gene Expression Testing for Prostate Cancer: Indications and Impact $0.00 For the most timely topics and latest surgical techniques in urology, you won't want to miss the 2016 AUA Update Series—AUA's most popular self-study CME product.Concise, practical lessons on timely topicsState-of-the-art surgical techniquesAuthors are among the best in their specialtiesEarn up to 40 AMA PRA Category 1 Credits™
Update Series (2019) Lesson 13: Sexual Health Care in Prostate Cancer Survivorship
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Now in its 38th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed in consultation with and edited by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology. 
Chemotherapy and Immunotherapy Options for Genitourinary Malignancies: A Primer for Urologists and Advanced Practice Providers Webcast 023IC (2019)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Review of current chemotherapy and immunotherapy regimens for genitourinary malignancies, including bladder, renal, prostate, and testis cancers. Indications, outcomes, and toxicities will be discussed as well as clinical trial concepts. Survivorship issues will also be a focus of the session, which will include short, direct didactic lectures as well as a question and answer period. Standard of care chemotherapy regimens (eg MVAC for urothelial carcinoma) as well as newer immunotherapy options (eg checkpoint inhibition for renal cell carcinoma) will be included.

Pages